ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 164 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $34,730 | -12.0% | 845 | 0.0% | 0.00% | -20.0% |
Q1 2024 | $39,453 | -2.4% | 845 | 0.0% | 0.01% | 0.0% |
Q4 2023 | $40,408 | +34.1% | 845 | 0.0% | 0.01% | +25.0% |
Q3 2023 | $30,124 | -22.7% | 845 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $38,980 | +15.0% | 845 | 0.0% | 0.01% | +20.0% |
Q1 2023 | $33,885 | -13.4% | 845 | 0.0% | 0.01% | -28.6% |
Q4 2022 | $39,149 | +11.9% | 845 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $35,000 | -30.0% | 845 | 0.0% | 0.01% | -30.0% |
Q2 2022 | $50,000 | -18.0% | 845 | 0.0% | 0.01% | -9.1% |
Q1 2022 | $61,000 | -14.1% | 845 | 0.0% | 0.01% | -15.4% |
Q4 2021 | $71,000 | -6.6% | 845 | 0.0% | 0.01% | -13.3% |
Q3 2021 | $76,000 | -6.2% | 845 | 0.0% | 0.02% | -11.8% |
Q2 2021 | $81,000 | -25.0% | 845 | -10.6% | 0.02% | -29.2% |
Q1 2021 | $108,000 | -17.6% | 945 | 0.0% | 0.02% | -20.0% |
Q4 2020 | $131,000 | +52.3% | 945 | -9.6% | 0.03% | +42.9% |
Q3 2020 | $86,000 | +4.9% | 1,045 | 0.0% | 0.02% | 0.0% |
Q2 2020 | $82,000 | +78.3% | 1,045 | 0.0% | 0.02% | +61.5% |
Q1 2020 | $46,000 | +2.2% | 1,045 | 0.0% | 0.01% | +18.2% |
Q4 2019 | $45,000 | 0.0% | 1,045 | 0.0% | 0.01% | -8.3% |
Q3 2019 | $45,000 | -31.8% | 1,045 | 0.0% | 0.01% | -29.4% |
Q2 2019 | $66,000 | -8.3% | 1,045 | 0.0% | 0.02% | -10.5% |
Q1 2019 | $72,000 | +60.0% | 1,045 | 0.0% | 0.02% | +58.3% |
Q4 2018 | $45,000 | -43.8% | 1,045 | 0.0% | 0.01% | -42.9% |
Q3 2018 | $80,000 | 0.0% | 1,045 | 0.0% | 0.02% | -4.5% |
Q2 2018 | $80,000 | +50.9% | 1,045 | 0.0% | 0.02% | +46.7% |
Q1 2018 | $53,000 | +10.4% | 1,045 | 0.0% | 0.02% | +7.1% |
Q4 2017 | $48,000 | -14.3% | 1,045 | 0.0% | 0.01% | -17.6% |
Q3 2017 | $56,000 | -13.8% | 1,045 | 0.0% | 0.02% | -19.0% |
Q2 2017 | $65,000 | +1.6% | 1,045 | +10.6% | 0.02% | 0.0% |
Q1 2017 | $64,000 | -16.9% | 945 | -13.7% | 0.02% | -22.2% |
Q4 2016 | $77,000 | -1.3% | 1,095 | 0.0% | 0.03% | +3.8% |
Q3 2016 | $78,000 | +44.4% | 1,095 | 0.0% | 0.03% | +36.8% |
Q2 2016 | $54,000 | -21.7% | 1,095 | 0.0% | 0.02% | -24.0% |
Q1 2016 | $69,000 | -34.9% | 1,095 | +15.9% | 0.02% | -34.2% |
Q4 2015 | $106,000 | +16.5% | 945 | 0.0% | 0.04% | +8.6% |
Q3 2015 | $91,000 | -24.2% | 945 | -19.6% | 0.04% | -22.2% |
Q2 2015 | $120,000 | +12.1% | 1,175 | -32.0% | 0.04% | +9.8% |
Q1 2015 | $107,000 | +40.8% | 1,728 | 0.0% | 0.04% | +36.7% |
Q4 2014 | $76,000 | -22.4% | 1,728 | 0.0% | 0.03% | -26.8% |
Q3 2014 | $98,000 | – | 1,728 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |